*To the Editor*:

Chronic obstructive pulmonary disease (COPD) is a disease that transcends specialties: internal medicine, pulmonary medicine, thoracic surgery, radiology, and so on. Its pathophysiology and management are taught in medical schools around the globe. The body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index is a well-known, widely used mortality predictor that is extensively described in medical literature ([@bib1]). It is a simple, yet important calculator that incorporates four factors to predict mortality in COPD: body mass index, obstruction measured by FEV~1~, dyspnea measured by the Modified Medical Research Council Dyspnea Scale, and exercise capacity measured by a 6-minute-walk test (6MWT). Although similar tools exist to predict mortality in patients with COPD, the BODE index has been transcendent and is the most widely used ([@bib2]). The index is synonymous with COPD. We believe its creator, Dr. Bartolome "Bart" R. Celli, should be the same. As a reflection of his lifetime achievement, we propose the BODE index be retitled the BART index.

Dr. Celli ([Figure 1](#fig1){ref-type="fig"}) has been recognized as a giant in chest medicine ([@bib3]). In 2004, he published a seminal paper in the *New England Journal of Medicine* and introduced the medical fraternity to the BODE index ([@bib1], [@bib3]). Through the years, this index has become an integral component of COPD management. It is well cited and is prevalent in contemporary medical literature. A query of PubMed alone yields 77 unique publications with the BODE index in the title.
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One of the advantages of the BODE index is the ease of its recollection: each letter represents a component that is accounted for in the score. A transition to the BART index would maintain this simplicity: body mass index, airway obstruction (measured by FEV~1~), respiratory symptoms (measured by Modified Medical Research Council Dyspnea Scale), and treading (measured by 6MWT). It even may be easier to recall than the BODE index, as the letters that represent FEV~1~ (airway obstruction vs. obstruction) and the 6MWT (treading vs. exercise) are more specific. Of course, we do not suggest any changes to the actual calculations themselves.

In summary, we believe this transition to the BART index from the BODE index maintains the spirit, essence, and science behind this important, ubiquitous calculator within thoracic medicine. This change will add to the legacy of the developer by honoring his name. In medicine, we have had a history of changing eponyms as a result of their dark pasts ([@bib4]). It would be refreshing to make a change to reflect on brilliant success and focus on celebration.

Originally Published in Press as DOI: [10.1164/rccm.201912-2443LE](http://dx.doi.org/10.1164/rccm.201912-2443LE) on January 17, 2020

[**[Author disclosures](http://www.atsjournals.org/doi/suppl/10.1164/rccm.201912-2443LE/suppl_file/disclosures.pdf)**]{.ul} are available with the text of this letter at [www.atsjournals.org](http://www.atsjournals.org).

[^1]: G.J.C. is Associate Editor of *AJRCCM*. His participation complies with American Thoracic Society requirements for recusal from review and decisions for authored works.
